Pharmacogenetics and target identification in diabetes.

Abstract excerpt

In diabetes, pharmacogenetics can be used both to identify patient subgroups who will have most benefit and/or least harm from a particularly treatment, and to gain insights into the molecular mechanisms of drug action and disease aetiology. There is increasing evidence that genetic variation alters response to diabetes treatments-both in terms of glycaemic response and side effects. This can be seen with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glucose Transporter Type 2
• Share to Hepatocyte Nuclear Factor 1-alpha
• Share to Infant, Newborn, Diseases